By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Genetics today said that it will sell 1,175,512 shares of its common stock to certain institutional investors, raising net proceeds of around $2.2 million.

The Los Angeles-based molecular diagnostics firm said that it would sell the shares at a price of $1.99 each through a registered direct offering to certain, unnamed investors. It expects to close the offering tomorrow.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.